Literature DB >> 23448372

Inhibition of cardiac inward rectifier currents by cationic amphiphilic drugs.

M A G van der Heyden1, A Stary-Weinzinger, J A Sanchez-Chapula.   

Abstract

Cardiac inward rectifier channels belong to three different classes of the KIR channel protein family. The KIR2.x proteins generate the classical inward rectifier current, IK1, while KIR3 and KIR6 members are responsible for the acetylcholine responsive and ATP sensitive inward rectifier currents IKAch and IKATP, respectively. Aberrant function of these channels has been correlated with severe cardiac arrhythmias, indicating their significant contribution to normal cardiac electrophysiology. A common feature of inward rectifier channels is their dependence on the lipid phosphatidyl-4,5-bisphospate (PIP2) interaction for functional activity. Cationic amphiphilic drugs (CADs) are one of the largest classes of pharmaceutical compounds. Several widely used CADs have been associated with inward rectifier current disturbances, and recent evidence points to interference of the channel-PIP2 interaction as the underlying mechanism of action. Here, we will review how six of these well known drugs, used for treatment in various different conditions, interfere in cardiac inward rectifier functioning. In contrast, KIR channel inhibition by the anionic anesthetic thiopental is achieved by a different mechanism of channel-PIP2 interference. We will discuss the latest basic science insights of functional inward rectifier current characteristics, recently derived KIR channel structures and specific PIP2-receptor interactions at the molecular level and provide insight in how these drugs interfere in the structure-function relationships.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23448372     DOI: 10.2174/15665240113139990043

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  4 in total

1.  Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP2 interference.

Authors:  Daniel Scherer; Benedikt Schworm; Claudia Seyler; Panagiotis Xynogalos; Eberhard P Scholz; Dierk Thomas; Hugo A Katus; Edgar Zitron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-04-02       Impact factor: 3.000

2.  Computational Identification of Novel Kir6 Channel Inhibitors.

Authors:  Xingyu Chen; Arthur Garon; Marcus Wieder; Marien J C Houtman; Eva-Maria Zangerl-Plessl; Thierry Langer; Marcel A G van der Heyden; Anna Stary-Weinzinger
Journal:  Front Pharmacol       Date:  2019-05-24       Impact factor: 5.988

Review 3.  Cardiac and renal inward rectifier potassium channel pharmacology: emerging tools for integrative physiology and therapeutics.

Authors:  Daniel R Swale; Sujay V Kharade; Jerod S Denton
Journal:  Curr Opin Pharmacol       Date:  2013-11-26       Impact factor: 5.547

4.  The inward rectifier current inhibitor PA-6 terminates atrial fibrillation and does not cause ventricular arrhythmias in goat and dog models.

Authors:  Yuan Ji; Rosanne Varkevisser; Dragan Opacic; Alexandre Bossu; Marion Kuiper; Jet D M Beekman; Sihyung Yang; Azinwi Phina Khan; Dobromir Dobrev; Niels Voigt; Michael Zhuo Wang; Sander Verheule; Marc A Vos; Marcel A G van der Heyden
Journal:  Br J Pharmacol       Date:  2017-06-28       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.